Literature DB >> 11997255

Aspartate aminotransferase isotope exchange reactions: implications for glutamate/glutamine shuttle hypothesis.

George A Kimmich1, James A Roussie, Joan Randles.   

Abstract

Aspartate aminotransferase (AAT) catalyzes amino group transfer from glutamate (Glu) or aspartate (Asp) to a keto acid acceptor-oxaloacetate (OA) or alpha-ketoglutarate (KG), respectively. Data presented here show that AAT catalyzes two partial reactions resulting in isotope exchange between 3H-labeled Glu or 3H-labeled Asp and the cognate keto acid in the absence of the keto acid acceptor required for the net reaction. Tritiated keto acid product was detected by release of 3H2O from C-3 during base-induced enolization. Tritium released directly from C-2 (or C-3) by the enzyme was also evaluated and is a small fraction of that released because of exchange to the keto acid pool. Exchange is dependent on AAT concentration, time-dependent, proportional to the amino-to-keto acid ratio, and blocked by aminooxyacetate (AOA), an AAT inhibitor. Enzymatic conversion of [3H]KG to Glu by glutamic dehydrogenase (GDH) or of [3H]OA to malate by malic dehydrogenase (MDH) "protects" the label from release by base, showing that base-induced isotope release is from keto acid rather than a result of release during the exchange process. AAT isotope exchange is discussed in the context of the glutamate/glutamine shuttle hypothesis for astrocyte/neuron carbon cycling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997255     DOI: 10.1152/ajpcell.00487.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  6 in total

Review 1.  Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain.

Authors:  Silvia Mangia; Federico Giove; Mauro Dinuzzo
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

2.  Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder.

Authors:  Karl Goodkin; Jeffry R Alger; Andrew A Maudsley; Varan Govind; Sulaiman Sheriff; Jingjing Michele Zhang
Journal:  Neuropsychiatry (London)       Date:  2012-10-01

3.  Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.

Authors:  Chika Watanabe; Yusuke Seino; Hiroki Miyahira; Michiyo Yamamoto; Ayako Fukami; Nobuaki Ozaki; Yoshiko Takagishi; Jun Sato; Tsutomu Fukuwatari; Katsumi Shibata; Yutaka Oiso; Yoshiharu Murata; Yoshitaka Hayashi
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

4.  Replication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis.

Authors:  Chun-Yuan Li; Yi-Jan Wang; Shiao-Wei Huang; Cheng-Shun Cheng; Han-Ching Wang
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  Characterization of Lysine Monomethylome and Methyltransferase in Model Cyanobacterium Synechocystis sp. PCC 6803.

Authors:  Xiaohuang Lin; Mingkun Yang; Xin Liu; Zhongyi Cheng; Feng Ge
Journal:  Genomics Proteomics Bioinformatics       Date:  2020-10-30       Impact factor: 7.691

6.  Dynamical differential networks and modules inferring disrupted genes associated with the progression of Alzheimer's disease.

Authors:  Zhengling Wang; Xinling Yan; Chenghua Zhao
Journal:  Exp Ther Med       Date:  2017-08-08       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.